Insights on COVID-19 Testing Rational and Outcomes Saving Lives with Dual Testing
August 11, 2020 — Lee’s Summit, MO.
Watch the video presentation from Dr. Kevin Latinis, MD/PhD, CoreMedica’s Chief Medical Office on COVID-19 Testing. Insights to rational and outcomes saving lives with dual testing.
About CoreMedica Laboratories, Inc.
CoreMedica is a diagnostic services company with operations in the US and EU. Founded 2010 in Lee’s Summit, Missouri, CoreMedica Labs spent its initial years developing the science, validating its methods, and implementing compliance to obtain College of American Pathologists (CAP) Accreditation and the Clinical Laboratory Improvement Amendments (CLIA) License. CoreMedica US is the first dried blood laboratory to receive CAP accreditation in 2014. The company provides a range of diagnostic services for corporate wellness, research, and pharmaceutical clients. In 2018 CoreMedica expanded its activities to Geneva, Switzerland to add the biological passport and innovative new technologies and advanced intellectual property to its portfolio of services.
CoreMedica’s current specimen analysis capabilities span across multiple collection modalities and methods, fingerstick, or venipuncture. Specimens from all across the world are processed at both of its United States (US) and European Union (EU) site laboratories daily. Its geographic footprint allows for industry leading turn-around time, consistency and quality.
Please Contact Us for more information.